FREE 2-DAY SHIPPING ON ORDERS $200+

Blog

Does Retatrutide Cause Hair Loss? What the Phase 3 Data Show

An inspection lamp on a steel stand lighting a fan of beige to brown color swatches on a white bench in a bright cosmetics science lab

In its trials, retatrutide took off more weight than tirzepatide or semaglutide did in theirs, and hair is where plenty of people expect to pay for it. Shedding is the side effect everyone has heard about from the older shots, so the first worry about the newer one is whether it is worse.

So far the record points the other way. Across 80 weeks and 2,339 adults in TRIUMPH-1, hair loss is missing from the trial’s list of 19 side effects reported by at least 5% of participants, a list that runs as far down as back pain and burping. Fast weight loss still thins hair in some people, and retatrutide produces a lot of fast weight loss. What helps is knowing when the shed arrives, who gets it and how to keep it small.

Retatrutide, Eli Lilly’s weekly triple agonist, works on the GLP-1, GIP and glucagon receptors at once, and the guide to what retatrutide is covers the compound itself.

Does retatrutide cause hair loss?

In a small share of people, and only for a while. Both of retatrutide’s published obesity trials keep hair loss under 5%, the cutoff trials use when they list common side effects.

In TRIUMPH-1, Lilly’s 80-week Phase 3 trial, the effects that cleared 5% were mostly stomach ones, plus smaller appetite, fatigue, headache and dizziness. Fatigue, for one, ran at 7.4% to 10.6% across the retatrutide doses against 3.6% on placebo. Hair loss does not appear at any dose. The 48-week Phase 2 trial used the same cutoff for its 338 participants, and hair loss stayed under it there too (Jastreboff, New England Journal of Medicine, 2023).

Under 5% is not zero. Pooled across trials of GLP-1 drugs, hair loss turns up about three times as often as on placebo, in roughly 3.9% of the people treated (Cheng, Diabetes Research and Clinical Practice, 2026). The weight coming off drives it, not anything the peptide does to the follicle, and that is the piece that carries over to retatrutide in full.

Outside trials it comes up even less. A 2026 study of 7,823 people who wrote online about symptoms from their own retatrutide use found hair loss named by 50 of them, 0.6% (Sehgal, JAMA Network Open, 2026). Nausea, skin sensation and the rest of the list, dose by dose, are in the guide to retatrutide side effects.

Three glass burettes on steel stands above conical flasks of clear and pale pink solution on a lab bench by sunny windows

Why retatrutide hair loss happens

The shedding is telogen effluvium, the scalp’s delayed answer to a hard physical change. At any moment about one scalp hair in seven is resting, waiting to fall. A steep drop in food or body weight tips a far bigger share of growing hairs into rest at once, and they let go together a few months later. Crash diets, major surgery, high fevers and giving birth set off the same shed.

Reviews of the whole drug class land in the same place. Pooling 17 studies and more than a million patient exposures, one 2026 analysis found GLP-1 drugs raised the odds of non-scarring hair loss by 40%, with telogen effluvium the main form. Alopecia areata, the autoimmune kind that leaves round bald patches, was not raised at all (Viquez Burboa, Skin Appendage Disorders, 2026). The authors traced it to weight loss and the vitamin and mineral shortfalls that come with eating far less.

A second review, one that took in retatrutide, named two predictors above the rest: being female and losing more than 10% of body weight (Leite Júnior, Acta Diabetologica, 2026). On retatrutide almost everyone clears the second. At Phase 2’s 48-week mark, 93% of the 12mg group had lost at least a tenth of their weight. Crossing that line raises the odds of a shed; the trial rates show it stays far from the rule.

When does retatrutide hair loss start?

If it comes, expect it somewhere between the third and the eighth month. Telogen shedding trails its trigger by two to four months, and on retatrutide the trigger is the run of months when weight drops quickest.

That stretch comes early. The trials open at 2mg and add a step every four weeks, reaching 12mg at week 17; every rung is in the retatrutide dosage chart. In Phase 2 the 12mg group was down 17.5% by week 24 and 24.2% by week 48, so close to three quarters of the first year’s loss landed in the first six months. Lay the hair clock over the weight clock and the shed starts around month three, runs heaviest over the next few months and eases as the weight curve flattens.

It looks like more hair on the pillow, in the brush and in the drain, and a part or ponytail that seems thinner. The loss spreads evenly over the scalp. Round patches, a hairline pulling back at the temples or a widening crown follow a different pattern, covered further down.

A researcher at an inverted microscope beside culture flasks of pink medium, with growing cells shown on a monitor in a bright lab

Does hair grow back after retatrutide?

Yes, in nearly every case. Telogen effluvium leaves the follicle whole, and it never takes a scalp bald. Each resting hair is pushed out by a new one starting below it, so the shed is itself the first stage of regrowth. In most people shedding is back to normal within six to nine months, and the first sign is a crop of short new hairs standing up along the hairline and the part.

Fullness takes longer than the shed. Scalp hair grows about half an inch a month, so long hair can take a year or more to feel as thick as it did, well after the extra shedding has stopped. The shed winds down once weight levels off, whether or not the weekly dose continues, since the weight loss was the trigger. What stopping does to the weight itself is in Can You Stop Retatrutide?

When the thinning keeps going

A shed can bring forward an inherited pattern of thinning that was on its way regardless. In the 2026 class analysis, androgenetic alopecia, the inherited male and female pattern, was diagnosed about 1.6 times as often in GLP-1 users at the one-year mark (Viquez Burboa, Skin Appendage Disorders, 2026). Thinning that carries on at the crown, the temples or the part after weight has held steady for a few months is that pattern rather than the shed, and it has treatments of its own.

Retatrutide hair loss in women and men

Women carry most of it. Retatrutide has no split by sex yet, so the nearest numbers come from tirzepatide, Lilly’s previous weight-loss peptide, where the gap ran about 14 to 1: 7.1% of women reported hair loss in the Zepbound trials, against 0.5% of men. Reviews of semaglutide and tirzepatide find the same tilt toward women.

Two things stack up for women on retatrutide. They lose more weight than men on the same dose, and iron tends to run low in women who menstruate, which deepens a shed on its own. Hair sits beside the other effects that land harder on women in side effects of retatrutide for women.

For men the shed itself is uncommon. What men tend to notice instead is a receding hairline or a thinning crown that was already coming, made visible sooner by a few months of extra shedding. That is the pattern above, and it keeps its own pace whether the weight loss continues or not.

Five glass vessels with steel lids in decreasing sizes linked by clear tubing on stirrer plates along a white lab bench

How to prevent hair loss on retatrutide

Put protein first on the plate. Hair is built from it, and it is the first thing to go missing when appetite shrinks. A 2025 joint advisory from obesity and nutrition medicine groups notes that 1.2 to 1.6 grams per kilogram a day has been proposed during active weight loss, against 0.8 for adults in general, and that for people with a lot to lose today’s full weight overstates the need (Mozaffarian, American Journal of Clinical Nutrition, 2025). Retatrutide’s third target, glucagon, also has the liver use up amino acids faster, one more reason to hold the habit. Protein also decides how much of the loss is muscle, the subject of muscle loss on retatrutide.

Keep calories off the floor. The same advisory puts the risk of running short on vitamins and minerals highest below about 1,200 calories a day for women and 1,800 for men, and lists heavy hair loss among the signs. Iron, zinc, vitamin B12 and vitamin D are the usual gaps, and a blood test settles which one is real before anything gets added.

Climb the doses the way the trials did. The 2mg start with a step every four weeks exists for the stomach, and it also keeps the first months’ weight loss from turning into a crash. Lilly’s knee trials also allowed a lower dose for anyone losing weight too quickly or reaching a BMI of 22.

Know what the vial holds. A dose ladder only means something when the vial’s content is known. The retatrutide batch Simms Research sells now went to an independent ISO-certified lab on July 16, 2026: three vials labeled 10mg came back at 10.68mg net content and 99.611% purity, and LC-MS confirmed the molecule. The retatrutide lab results page carries the full record, and the retatrutide calculator turns each rung into syringe units. Retatrutide (GLP-3) is sold in four vial sizes, 10mg up to 60mg.

Retatrutide vs tirzepatide and semaglutide hair loss

Of the three, tirzepatide is the one where hair loss made the common side effect list. Retatrutide, with more weight lost, has not, and semaglutide sits below tirzepatide on weight and hair alike:

Drug and trialLengthWeight lost, top doseHair loss on the drugHair loss on placebo
Retatrutide, TRIUMPH-180 weeks25.0%Under 5%Under 5%
Retatrutide, Phase 248 weeks24.2%Under 5%Under 5%
Tirzepatide (Zepbound)72 weeks20.9%4% to 5%1%
Semaglutide (Wegovy)68 weeks14.9%3%1%

The weight column and the hair column do not line up neatly, and dose made no difference within tirzepatide, where 5mg, 10mg and 15mg all landed at 4% to 5%. Semaglutide is where dose shows: hair loss clusters at the 2.4mg weight-loss dose and rarely appears under 2mg a week (Gupta, Science Progress, 2026). These are separate trials, never a head-to-head. The retatrutide vs tirzepatide comparison sets the two Lilly peptides side by side, and Does Tirzepatide Cause Hair Loss? has tirzepatide’s own numbers in full.

Frequently asked questions

Does GLP-3 cause hair loss?

GLP-3 is the name research shops give retatrutide, and reta peptide is its short form, so the answer is the same: under 5% in the trials, as a temporary shed that trails fast weight loss. What Is GLP-3? explains where the label came from.

Does lowering the dose stop retatrutide hair loss?

It slows the trigger, not the shed already under way. Hairs falling this month were tipped into rest two to four months earlier, so a lower dose shows up in the brush months later, if at all. A step down makes sense when weight is dropping faster than planned, the reason the trials allowed one.

Can hair loss start after stopping retatrutide?

Yes. The lag runs two to four months, so a shed set off by the last stretch of fast loss can arrive after the final dose. It follows the same course and settles the same way.

Does biotin help with retatrutide hair loss?

Rarely. It helps someone actually short of it, which is uncommon. High doses also skew some blood tests, thyroid and heart tests among them, which can blur the very results worth checking when shedding runs long.

Keep exploring

Verify the underlying batch data

Compare published methods and results, then open the source certificate for the batch you are evaluating.

Browse lab results